|
|
Previous Article | Table of Contents | Next Article 
Blood, Vol. 96 No. 3 (August 1), 2000:
pp. 840-845
LEC induces chemotaxis and adhesion by interacting with CCR1 and
CCR8
O. M. Zack Howard,
Hui Fang Dong,
Aiko-Konno Shirakawa, and
Joost J. Oppenheim
From the Intramural Research Support Program, Laboratory of
Molecular Immunoregulation, Division of Basic Science, National Cancer
Institute-Frederick Cancer Research and Development Center, Frederick,
MD.
Liver-expressed chemokine (LEC) is an unusually large CC chemokine,
which is also known as LMC, HCC-4, NCC-4, and CCL16. Previously, LEC
was shown to induce leukocyte migration but the responsible signaling
receptors were not characterized. We report chemotaxis and competitive
binding studies that show LEC binds to and activates CCR1 and CCR8
transfected HEK-293 cells. LEC induced maximal migration of CCR1 and
CCR8 transfected cells at 89.3 nmol/L and cell adhesion at 5.6 nmol/L.
The molar concentration of LEC required to induce maximum cell
migration is 20- to 200-fold greater than that required for RANTES or
I309, respectively. All 3 chemokines induced maximal static adhesion at
5 to 7 nmol/L. A neutralizing polyclonal antibody to LEC was developed
to demonstrate that the unusually high concentration of LEC required to
induce chemotaxis was a property of LEC and not as a result of an
irrelevant protein contamination. This study suggests that LEC may be a
more effective inducer of cell adhesion than cell migration.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. M. Fox, P. Najarro, G. L. Smith, S. Struyf, P. Proost, and J. E. Pease
Structure/Function Relationships of CCR8 Agonists and Antagonists: AMINO-TERMINAL EXTENSION OF CCL1 BY A SINGLE AMINO ACID GENERATES A PARTIAL AGONIST
J. Biol. Chem.,
December 1, 2006;
281(48):
36652 - 36661.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Cappello, T. Fraone, L. Barberis, C. Costa, E. Hirsch, A. R. Elia, C. Caorsi, T. Musso, F. Novelli, and M. Giovarelli
CC-Chemokine Ligand 16 Induces a Novel Maturation Program in Human Immature Monocyte-Derived Dendritic Cells
J. Immunol.,
November 1, 2006;
177(9):
6143 - 6151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J J Haringman, T J M Smeets, P Reinders-Blankert, and P P Tak
Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis
Ann Rheum Dis,
March 1, 2006;
65(3):
294 - 300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nakayama, Y. Kato, K. Hieshima, D. Nagakubo, Y. Kunori, T. Fujisawa, and O. Yoshie
Liver-Expressed Chemokine/CC Chemokine Ligand 16 Attracts Eosinophils by Interacting with Histamine H4 Receptor
J. Immunol.,
August 1, 2004;
173(3):
2078 - 2083.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Guiducci, E. Di Carlo, M. Parenza, M. Hitt, M. Giovarelli, P. Musiani, and M. P. Colombo
Intralesional Injection of Adenovirus Encoding CC Chemokine Ligand 16 Inhibits Mammary Tumor Growth and Prevents Metastatic-Induced Death after Surgical Removal of the Treated Primary Tumor
J. Immunol.,
April 1, 2004;
172(7):
4026 - 4036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Cappello, C. Caorsi, M. Bosticardo, S. De Angelis, F. Novelli, G. Forni, and M. Giovarelli
CCL16/LEC powerfully triggers effector and antigen-presenting functions of macrophages and enhances T cell cytotoxicity
J. Leukoc. Biol.,
January 1, 2004;
75(1):
135 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Strasly, G. Doronzo, P. Capello, D. Valdembri, M. Arese, S. Mitola, P. Moore, G. Alessandri, M. Giovarelli, and F. Bussolino
CCL16 activates an angiogenic program in vascular endothelial cells
Blood,
January 1, 2004;
103(1):
40 - 49.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Li, P. Hu, L. A. Khawli, and A. L. Epstein
Complete Regression of Experimental Solid Tumors by Combination LEC/chTNT-3 Immunotherapy and CD25+ T-Cell Depletion
Cancer Res.,
December 1, 2003;
63(23):
8384 - 8392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nomiyama, K. Hieshima, T. Nakayama, T. Sakaguchi, R. Fujisawa, S. Tanase, H. Nishiura, K. Matsuno, H. Takamori, Y. Tabira, et al.
Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes
Int. Immunol.,
August 1, 2001;
13(8):
1021 - 1029.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. W. Chensue, N. W. Lukacs, T.-Y. Yang, X. Shang, K. A. Frait, S. L. Kunkel, T. Kung, M. T. Wiekowski, J. A. Hedrick, D. N. Cook, et al.
Aberrant In Vivo T Helper Type 2 Cell Response and Impaired Eosinophil Recruitment in CC Chemokine Receptor 8 Knockout Mice
J. Exp. Med.,
February 26, 2001;
193(5):
573 - 584.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|